MIAMI (AP) — Tropical Storm Jerry churned Thursday in the Atlantic on its approach to the Leeward Islands as Tropical Storm Priscilla and Tropical Storm Raymond moved along Mexico’s Pacific coast, ...

Timed to coincide with the upcoming Banned Books Week and Let Freedom Read Day, October 5–11, PEN America has released its annual report on censorship in public schools. The data further supports the ...

On Wednesday, Meta announced that it would use conversations with its AI chatbot to tailor ads. Advertising is a core business for Meta, comprising over 97% of its revenue in 2023 and 2024. Meta AI ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Forecasters predict "dangerous marine conditions" will impact portions of the U.S. and other areas due to the storms Abigail Adams is a Human Interest Writer and Reporter for PEOPLE. She has been ...

BOSTON — The Boston Red Sox are about to embark on their third trip to the postseason under manager Alex Cora, and like the first two, the playoffs begin with a series against the New York Yankees.

Third-party models from Google and Black Forest Labs will be available to use in Photoshop beta for the first time. Katelyn is a writer with CNET covering artificial intelligence, including chatbots, ...

Why do our playlists shrink as we age, even as algorithms flood us with endless new music? A new study tracks listening habits across decades and shows how our tastes evolve—and how streaming ...

Air travellers are facing another day of disruption at several European airports including Heathrow, after a cyber-attack knocked out a check-in and baggage system. There were hundreds of delays on ...

AMSTERDAM & BOSTON & SEATTLE--(BUSINESS WIRE)--VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, and ...

VectorY Therapeutics and Shape Therapeutics Announce Option and License Agreement to Advance Vectorized Antibodies for Neurodegenerative Diseases Using an AAV5-Derived CNS Capsid ~ Agreement grants ...